Pharmaceutical News and Articles

Stillbirth Rates Are Highest in the South

Women in the U.S. South are three times more likely to lose a baby in late pregnancy than mothers in other regions, a new study reports. The study, exclusively

Recent Decade Saw No Change in Diabetes Prevalence in U.S. Adults

Between 2013 and 2023, there was no change in the prevalence of diabetes among U.S. adults, but glycemic control worsened, according to a research letter publis

Could Your Cup of Tea Help Remove Lead From Drinking Water?

it could also help remove harmful heavy metals from your drinking water, new research suggests. A Northwestern University study found that tea leaves can natura

Combination, Aerobic Exercise Improves Sleep Quality in Seniors

Exercise, particularly strengthening exercise and aerobic exercise, can improve the sleep quality of older adults, according to a review published online March

Makers of Wegovy & Zepbound Cut Prices for Those Without Insurance

The makers of two popular weight-loss drugs Wegovy and Zepbound are cutting prices to make the medications more affordable for people without insurance. takes e

Bladder Wall Thickness Reflects Severity of Bladder Inflammatory Conditions

For patients with interstitial cystitis bladder pain syndrome (IC BPS), bladder wall thickness (BWT) on computed tomography (CT) scans reflects the severity of

Higher Intake of Butter Linked to Increased Mortality

Higher intake of butter is associated with increased mortality, according to a study published online March 6 in JAMA Internal Medicine to coincide with the Ame

Risk for Lymphoma, Skin Cancer Increased in Individuals With Tattoos

Tattooed individuals have an increased risk for lymphoma and skin cancers, according to a study recently published in BMC Public Health. Signe Bedsted Clemmense

Second Death From Measles Reported in Unvaccinated Adult in New Mexico

Amid the current outbreak of measles centered in counties along the Texas New Mexico border, the New Mexico Department of Health (NMDOH) is reporting the death

FDA Approves Omlyclo (omalizumab-igec), an Interchangeable Biosimilar to Xolair